LONDON, Feb. 07, 2019 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, will announce on 26 February, 2019 its financial results for the quarter ending 31 December, 2018. This is a transition period as GW will be moving to a new fiscal year-ending 31 December following this report on Form 10K-T. GW will also host a conference call the same day at 4:30 p.m. EST. Conference call information will be provided in the financial results press release. A replay of the call will also be available through the Company’s website (www.gwpharm.com) shortly after the call.
About GW Pharmaceuticals plc and Greenwich Biosciences, Inc.
Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its
... read more at: https://globenewswire.com/news-release/2019/02/07/1713661/0/en/GW-Pharmaceuticals-plc-to-Report-Financial-Results-and-Operational-Progress-for-the-Period-Ending-31-December-2018-and-Host-Conference-Call-on-26-February-2019.html